LYELLyell Immunopharma, Inc.
- Market cap
- $230.10M
- as of 2026-10-23
- Latest close
- $9.39
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-11-20
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Aguirre Jarrad MattieuChief Medical Officer | Oct 12 | Oct 13 | S | 422 | $8.63 | Sale −$3,642 | 19,857 | No | Form 4 |
| Shook DavidChief Medical Officer | Sep 10 | Sep 10 | S | 500 | $12.70 | Sale −$6,350 | 20,423 | No | Form 4 |
| Aguirre Jarrad MattieuChief Medical Officer | Sep 10 | Sep 10 | A · derivative | 47,500 | $12.20 | $579,500 | 47,500 | No | Form 4 |
| Seely LynnPresident and CEO | Aug 21 | Aug 25 | S | 9,589 | $15.54 | Sale −$149,013 | 63,899 | No | Form 4 |
| Hill Stephen J.Chief Operating Officer | Aug 21 | Aug 25 | S | 989 | $15.54 | Sale −$15,369 | 16,816 | No | Form 4 |
| Lee Gary K.Chief Scientific Officer | Aug 21 | Aug 25 | S | 1,457 | $15.54 | Sale −$22,642 | 16,220 | No | Form 4 |
| Seely LynnPresident and CEO | Aug 10 | Aug 11 | S | 390 | $14.34 | Sale −$5,593 | 73,488 | No | Form 4 |
| Hill Stephen J.Chief Operating Officer | Aug 10 | Aug 11 | S | 89 | $14.34 | Sale −$1,276 | 17,805 | No | Form 4 |
| Lee Gary K.Chief Scientific Officer | Aug 10 | Aug 11 | S | 131 | $14.34 | Sale −$1,879 | 17,677 | No | Form 4 |
| Bulis Veronica SanchezVP, Corporate Controller | Aug 10 | Aug 11 | S | 621 | $14.34 | Sale −$8,905 | 14,799 | No | Form 4 |
| Innovative Cellular Therapeutics Holdings Ltd | Jul 27 | Jul 27 | J | 38,500 | $0.00 | $0 | 2,818,980 | No | Form 4 |
| Innovative Cellular Therapeutics Holdings Ltd | Jul 27 | Jul 27 | J | 44,000 | $0.00 | $0 | 2,774,980 | No | Form 4 |
| Innovative Cellular Therapeutics Holdings Ltd | Jul 17 | Jul 20 | S | 10 | $13.70 | Sale −$137 | 2,857,480 | Yes | Form 4 |
| Innovative Cellular Therapeutics Holdings Ltd | Jul 16 | Jul 17 | S | 10 | $13.73 | Sale −$137 | 2,857,490 | Yes | Form 4 |
| Innovative Cellular Therapeutics Holdings Ltd | Jun 29 | Jul 1 | J | 76,000 | $0.00 | $0 | 2,857,500 | No | Form 4 |
| Innovative Cellular Therapeutics Holdings Ltd | Jun 15 | Jun 18 | J | 66,500 | $0.00 | $0 | 2,933,500 | No | Form 4 |
| Seely LynnPresident and CEO | May 11 | Jun 15 | S | 388 | $18.91 | Sale −$7,337 | 73,878 | No | Form 4 |
| Hill Stephen J.Chief Operating Officer | May 11 | Jun 15 | S | 89 | $18.92 | Sale −$1,684 | 17,894 | No | Form 4 |
| Lee Gary K.Chief Scientific Officer | May 11 | Jun 15 | S | 130 | $18.92 | Sale −$2,460 | 17,808 | No | Form 4 |
| Bulis Veronica SanchezVP, Corporate Controller | May 11 | Jun 15 | S | 217 | $18.91 | Sale −$4,103 | 15,420 | No | Form 4 |
| Rieflin William Jl | Jun 10 | Jun 12 | A · derivative | 9,250 | $13.22 | $122,285 | 9,250 | No | Form 4 |
| Brawley Otis W | Jun 10 | Jun 12 | A · derivative | 9,250 | $13.22 | $122,285 | 9,250 | No | Form 4 |
| Friedman Cathy | Jun 10 | Jun 12 | A · derivative | 9,250 | $13.22 | $122,285 | 9,250 | No | Form 4 |
| Ramachandra Sumant | Jun 10 | Jun 12 | A · derivative | 9,250 | $13.22 | $122,285 | 9,250 | No | Form 4 |
| Klausner Richard | Jun 10 | Jun 12 | A · derivative | 9,250 | $13.22 | $122,285 | 9,250 | No | Form 4 |
| Nabel Elizabeth G | Jun 10 | Jun 12 | A · derivative | 9,250 | $13.22 | $122,285 | 9,250 | No | Form 4 |
| Bachleda Mark | Jun 10 | Jun 12 | A · derivative | 9,250 | $13.22 | $122,285 | 9,250 | No | Form 4 |
| Shook DavidChief Medical Officer | Jun 10 | Jun 11 | S | 1,977 | $12.64 | Sale −$24,989 | 20,923 | No | Form 4 |
| Shah SmitalChief Fin. and Bus. Officer | Mar 9 | Mar 16 | A · derivative | 140,000 | $25.50 | $3,570,000 | 140,000 | No | Form 4 |
| Berns Paul L | Mar 6 | Mar 9 | P | 488,090 | $25.61 | Purchase +$12,499,985 | 1,426,528 | No | Form 4 |
| ARCH Venture Partners IX Overage, L.P. | Mar 6 | Mar 9 | P | 488,090 | $25.61 | Purchase +$12,499,985 | 1,426,528 | No | Form 4 |
| Seely LynnPresident and CEO | Feb 11 | Feb 12 | S | 7,455 | $23.39 | Sale −$174,372 | 74,266 | No | Form 4 |
| Hill Stephen J.Chief Operating Officer | Feb 11 | Feb 12 | S | 1,236 | $23.39 | Sale −$28,910 | 17,795 | No | Form 4 |
| Lee Gary K.Chief Scientific Officer | Feb 11 | Feb 12 | S | 1,671 | $23.39 | Sale −$39,085 | 16,938 | No | Form 4 |
| Seely LynnPresident and CEO | Feb 10 | Feb 11 | S | 438 | $23.12 | Sale −$10,127 | 81,721 | No | Form 4 |
| Seely LynnPresident and CEO | Feb 10 | Feb 11 | A · derivative | 155,000 | $23.71 | $3,675,050 | 155,000 | No | Form 4 |
| Meltz Mark AGeneral Counsel | Feb 10 | Feb 11 | A · derivative | 50,000 | $23.71 | $1,185,500 | 50,000 | No | Form 4 |
| Hill Stephen J.Chief Operating Officer | Feb 10 | Feb 11 | S | 109 | $23.12 | Sale −$2,520 | 19,031 | No | Form 4 |
| Hill Stephen J.Chief Operating Officer | Feb 10 | Feb 11 | A · derivative | 65,000 | $23.71 | $1,541,150 | 65,000 | No | Form 4 |
| Lee Gary K.Chief Scientific Officer | Feb 10 | Feb 11 | S | 147 | $23.12 | Sale −$3,399 | 18,609 | No | Form 4 |
| Lee Gary K.Chief Scientific Officer | Feb 10 | Feb 11 | A · derivative | 50,000 | $23.71 | $1,185,500 | 50,000 | No | Form 4 |
| Shook DavidChief Medical Officer | Feb 10 | Feb 11 | A · derivative | 50,000 | $23.71 | $1,185,500 | 50,000 | No | Form 4 |
| Bulis Veronica SanchezVP, Corporate Controller | Feb 10 | Feb 11 | A | 8,750 | $0.00 | $0 | 15,891 | No | Form 4 |
| Bulis Veronica SanchezVP, Corporate Controller | Feb 10 | Feb 11 | S | 254 | $23.12 | Sale −$5,872 | 15,637 | No | Form 4 |
| Seely LynnPresident and CEO | Feb 9 | Feb 11 | A | 20,000 | $0.00 | $0 | 82,159 | No | Form 4 |
| Hill Stephen J.Chief Operating Officer | Feb 9 | Feb 11 | A | 4,000 | $0.00 | $0 | 19,140 | No | Form 4 |
| Lee Gary K.Chief Scientific Officer | Feb 9 | Feb 11 | A | 4,000 | $0.00 | $0 | 18,756 | No | Form 4 |
| Bulis Veronica SanchezVP, Corporate Controller | Dec 30, 2025 | Jan 6 | S | 936 | $32.32 | Sale −$30,252 | 7,141 | No | Form 4 |
| Bulis Veronica SanchezVP, Corporate Controller | Dec 24, 2025 | Jan 6 | S | 1,136 | $38.67 | Sale −$43,929 | 8,077 | No | Form 4 |
| Seely LynnPresident and CEO | Nov 10, 2025 | Nov 12, 2025 | S | 412 | $16.11 | Sale −$6,637 | 67,159 | No | Form 4 |
| Hill Stephen J.Chief Operating Officer | Nov 10, 2025 | Nov 12, 2025 | S | 95 | $16.12 | Sale −$1,531 | 15,750 | No | Form 4 |
| Lee Gary K.Chief Scientific Officer | Nov 10, 2025 | Nov 12, 2025 | S | 138 | $16.16 | Sale −$2,230 | 15,366 | No | Form 4 |
| Bulis Veronica SanchezVP, Corporate Controller | Nov 10, 2025 | Nov 12, 2025 | S | 239 | $16.10 | Sale −$3,848 | 9,213 | No | Form 4 |
| Seely LynnPresident and CEO | Oct 27, 2025 | Oct 29, 2025 | A · derivative | 175,000 | $17.23 | $3,015,250 | 175,000 | No | Form 4 |
| Hill Stephen J.Chief Operating Officer | Oct 27, 2025 | Oct 29, 2025 | A · derivative | 75,000 | $17.23 | $1,292,250 | 75,000 | No | Form 4 |
| Lee Gary K.Chief Scientific Officer | Oct 27, 2025 | Oct 29, 2025 | A · derivative | 68,000 | $17.23 | $1,171,640 | 68,000 | No | Form 4 |
| Lee Gary K.Chief Scientific Officer | Aug 21, 2025 | Aug 22, 2025 | S | 1,453 | $10.54 | Sale −$15,315 | 15,504 | No | Form 4 |
| Newton Charles W.Chief Financial Officer | Aug 21, 2025 | Aug 22, 2025 | S | 1,453 | $10.54 | Sale −$15,315 | 15,306 | No | Form 4 |
| Hill Stephen J.Chief Operating Officer | Aug 21, 2025 | Aug 22, 2025 | S | 1,004 | $10.54 | Sale −$10,582 | 15,845 | No | Form 4 |
| Seely LynnPresident and CEO | Aug 21, 2025 | Aug 22, 2025 | S | 7,257 | $10.54 | Sale −$76,489 | 67,571 | No | Form 4 |
| Lee Gary K.Chief Scientific Officer | Aug 20, 2025 | Aug 22, 2025 | A | 8,000 | $0.00 | $0 | 16,957 | No | Form 4 |
| Newton Charles W.Chief Financial Officer | Aug 20, 2025 | Aug 22, 2025 | A | 8,000 | $0.00 | $0 | 16,759 | No | Form 4 |
| Hill Stephen J.Chief Operating Officer | Aug 20, 2025 | Aug 22, 2025 | A | 8,000 | $0.00 | $0 | 16,849 | No | Form 4 |
| Seely LynnPresident and CEO | Aug 20, 2025 | Aug 22, 2025 | A | 40,000 | $0.00 | $0 | 74,828 | No | Form 4 |
| Newton Charles W.Chief Financial Officer | Aug 12, 2025 | Aug 13, 2025 | S | 136 | $10.34 | Sale −$1,406 | 8,759 | No | Form 4 |
| Lee Gary K.Chief Scientific Officer | Aug 12, 2025 | Aug 13, 2025 | S | 136 | $10.34 | Sale −$1,406 | 8,957 | No | Form 4 |
| Hill Stephen J.Chief Operating Officer | Aug 12, 2025 | Aug 13, 2025 | S | 94 | $10.34 | Sale −$972 | 8,849 | No | Form 4 |
| Seely LynnPresident and CEO | Aug 12, 2025 | Aug 13, 2025 | S | 406 | $10.34 | Sale −$4,198 | 34,828 | No | Form 4 |
| Newton Charles W.Chief Financial Officer | Aug 11, 2025 | Aug 13, 2025 | S | 131 | $10.53 | Sale −$1,379 | 8,895 | No | Form 4 |
| Lee Gary K.Chief Scientific Officer | Aug 11, 2025 | Aug 13, 2025 | S | 131 | $10.53 | Sale −$1,379 | 9,093 | No | Form 4 |
| Hill Stephen J.Chief Operating Officer | Aug 11, 2025 | Aug 13, 2025 | S | 91 | $10.53 | Sale −$958 | 8,943 | No | Form 4 |
| Seely LynnPresident and CEO | Aug 11, 2025 | Aug 13, 2025 | S | 391 | $10.53 | Sale −$4,117 | 35,234 | No | Form 4 |
| Shook DavidChief Medical Officer | Jun 9, 2025 | Jun 11, 2025 | A | 21,900 | $0.00 | $0 | 21,900 | No | Form 4 |
| Shook DavidChief Medical Officer | Jun 9, 2025 | Jun 11, 2025 | A · derivative | 43,750 | $12.47 | $545,563 | 43,750 | No | Form 4 |
| Meltz Mark AGeneral Counsel | Jun 9, 2025 | Jun 11, 2025 | A · derivative | 100,000 | $12.47 | $1,247,000 | 100,000 | No | Form 4 |
| Bachleda Mark | Jun 9, 2025 | Jun 11, 2025 | A · derivative | 13,000 | $12.47 | $162,110 | 13,000 | No | Form 4 |
| Ramachandra Sumant | May 15, 2025 | May 19, 2025 | A · derivative | 130,000 | $0.40 | $52,000 | 130,000 | No | Form 4 |
| Nabel Elizabeth G | May 15, 2025 | May 19, 2025 | A · derivative | 130,000 | $0.40 | $52,000 | 130,000 | No | Form 4 |
| Brawley Otis W | May 15, 2025 | May 19, 2025 | A · derivative | 130,000 | $0.40 | $52,000 | 130,000 | No | Form 4 |
| Friedman Cathy | May 15, 2025 | May 19, 2025 | A · derivative | 130,000 | $0.40 | $52,000 | 130,000 | No | Form 4 |
| Rieflin William Jl | May 15, 2025 | May 19, 2025 | A · derivative | 130,000 | $0.40 | $52,000 | 130,000 | No | Form 4 |
| Klausner Richard | May 15, 2025 | May 19, 2025 | A · derivative | 130,000 | $0.40 | $52,000 | 130,000 | No | Form 4 |
| Brawley Otis W | Mar 31, 2025 | Apr 2, 2025 | P | 35,640 | $0.56 | Purchase +$19,958 | 35,640 | No | Form 4 |
| Ramachandra Sumant | Mar 21, 2025 | Mar 25, 2025 | P | 200,000 | $0.58 | Purchase +$116,000 | 200,000 | No | Form 4 |
| Newton Charles W.Chief Financial Officer | Mar 17, 2025 | Mar 18, 2025 | P | 200,000 | $0.56 | Purchase +$112,000 | 200,000 | No | Form 4 |
| Seely LynnPresident and CEO | Mar 14, 2025 | Mar 18, 2025 | P | 175,000 | $0.61 | Purchase +$106,750 | 712,500 | No | Form 4 |
| Klausner Richard | Mar 14, 2025 | Mar 18, 2025 | P | 158,000 | $0.60 | Purchase +$94,800 | 843,365 | No | Form 4 |
| Lee Gary K.Chief Scientific Officer | Feb 10, 2025 | Feb 26, 2025 | A | 112,500 | $0.00 | $0 | 176,696 | No | Form 4 |
| Lee Gary K.Chief Scientific Officer | Feb 10, 2025 | Feb 26, 2025 | A · derivative | 450,000 | $0.55 | $247,500 | 450,000 | No | Form 4 |
| Lee Gary K.Chief Scientific Officer | Feb 10, 2025 | Feb 26, 2025 | A · derivative | 56,250 | $0.55 | $30,938 | 56,250 | No | Form 4 |
| Newton Charles W.Chief Financial Officer | Feb 10, 2025 | Feb 26, 2025 | A | 112,500 | $0.00 | $0 | 172,725 | No | Form 4 |
| Newton Charles W.Chief Financial Officer | Feb 10, 2025 | Feb 26, 2025 | A · derivative | 450,000 | $0.55 | $247,500 | 450,000 | No | Form 4 |
| Newton Charles W.Chief Financial Officer | Feb 10, 2025 | Feb 26, 2025 | A · derivative | 56,250 | $0.55 | $30,938 | 56,250 | No | Form 4 |
| Hill Stephen J.Chief Operating Officer | Feb 10, 2025 | Feb 26, 2025 | A | 112,500 | $0.00 | $0 | 172,899 | No | Form 4 |
| Hill Stephen J.Chief Operating Officer | Feb 10, 2025 | Feb 26, 2025 | A · derivative | 450,000 | $0.55 | $247,500 | 450,000 | No | Form 4 |
| Hill Stephen J.Chief Operating Officer | Feb 10, 2025 | Feb 26, 2025 | A · derivative | 56,250 | $0.55 | $30,938 | 56,250 | No | Form 4 |
| Seely LynnPresident and CEO | Feb 10, 2025 | Feb 26, 2025 | A | 337,500 | $0.00 | $0 | 537,500 | No | Form 4 |
| Seely LynnPresident and CEO | Feb 10, 2025 | Feb 26, 2025 | A · derivative | 1,350,000 | $0.55 | $742,500 | 1,350,000 | No | Form 4 |
| Seely LynnPresident and CEO | Feb 10, 2025 | Feb 26, 2025 | A · derivative | 168,750 | $0.55 | $92,813 | 168,750 | No | Form 4 |
| Lang MatthewChief Business Officer | Feb 10, 2025 | Feb 26, 2025 | A | 112,500 | $0.00 | $0 | 162,500 | No | Form 4 |
| Lang MatthewChief Business Officer | Feb 10, 2025 | Feb 26, 2025 | A · derivative | 450,000 | $0.55 | $247,500 | 450,000 | No | Form 4 |
| Lang MatthewChief Business Officer | Feb 10, 2025 | Feb 26, 2025 | A · derivative | 56,250 | $0.55 | $30,938 | 56,250 | No | Form 4 |
| Ramachandra Sumant | Oct 31, 2024 | Nov 1, 2024 | A · derivative | 260,000 | $0.96 | $249,600 | 260,000 | No | Form 4 |
| Friedman Cathy | Jun 14, 2024 | Jun 17, 2024 | A · derivative | 130,000 | $2.36 | $306,800 | 130,000 | No | Form 4 |
| Brawley Otis W | Jun 14, 2024 | Jun 17, 2024 | A · derivative | 130,000 | $2.36 | $306,800 | 130,000 | No | Form 4 |
| Nabel Elizabeth G | Jun 14, 2024 | Jun 17, 2024 | A · derivative | 130,000 | $2.36 | $306,800 | 130,000 | No | Form 4 |
| Rieflin William Jl | Jun 14, 2024 | Jun 17, 2024 | A · derivative | 130,000 | $2.36 | $306,800 | 130,000 | No | Form 4 |
| Klausner Richard | Jun 14, 2024 | Jun 17, 2024 | A · derivative | 130,000 | $2.36 | $306,800 | 130,000 | No | Form 4 |
| Bishop Hans Edgar | Jun 14, 2024 | Jun 17, 2024 | A · derivative | 130,000 | $2.36 | $306,800 | 130,000 | No | Form 4 |
| Nelsen Robert | Jun 14, 2024 | Jun 17, 2024 | A · derivative | 130,000 | $2.36 | $306,800 | 130,000 | No | Form 4 |
| Seely LynnPresident and CEO | Feb 9, 2024 | Feb 13, 2024 | A | 200,000 | $0.00 | $0 | 200,000 | No | Form 4 |
| Newton Charles W.Chief Financial Officer | Feb 9, 2024 | Feb 13, 2024 | A | 40,000 | $0.00 | $0 | 48,729 | No | Form 4 |
| Newton Charles W.Chief Financial Officer | Feb 9, 2024 | Feb 13, 2024 | A · derivative | 400,000 | $1.80 | $720,000 | 400,000 | No | Form 4 |
| Lee Gary K.Chief Scientific Officer | Feb 9, 2024 | Feb 13, 2024 | A | 40,000 | $0.00 | $0 | 52,700 | No | Form 4 |
| Lee Gary K.Chief Scientific Officer | Feb 9, 2024 | Feb 13, 2024 | A · derivative | 400,000 | $1.80 | $720,000 | 400,000 | No | Form 4 |
| Hill Stephen J.Chief Operating Officer | Feb 9, 2024 | Feb 13, 2024 | A | 40,000 | $0.00 | $0 | 48,928 | No | Form 4 |
| Hill Stephen J.Chief Operating Officer | Feb 9, 2024 | Feb 13, 2024 | A · derivative | 400,000 | $1.80 | $720,000 | 400,000 | No | Form 4 |
| Lang MatthewChief Business Officer | Feb 9, 2024 | Feb 13, 2024 | A | 50,000 | $0.00 | $0 | 50,000 | No | Form 4 |
| Lang MatthewChief Business Officer | Feb 9, 2024 | Feb 13, 2024 | A · derivative | 500,000 | $1.80 | $900,000 | 500,000 | No | Form 4 |
| Hill Stephen J.Chief Technical Ops. Officer | Nov 16, 2023 | Nov 20, 2023 | A · derivative | 500,000 | $1.87 | $935,000 | 500,000 | No | Form 4 |
| Hill Stephen J.Chief Technical Ops. Officer | Nov 16, 2023 | Nov 20, 2023 | D · derivative | 500,000 | $3.65 | $1,825,000 | not reported | No | Form 4 |
| Hill Stephen J.Chief Technical Ops. Officer | Nov 16, 2023 | Nov 20, 2023 | A · derivative | 165,000 | $1.87 | $308,550 | 165,000 | No | Form 4 |
| Hill Stephen J.Chief Technical Ops. Officer | Nov 16, 2023 | Nov 20, 2023 | D · derivative | 165,000 | $3.65 | $602,250 | not reported | No | Form 4 |
| Hill Stephen J.Chief Technical Ops. Officer | Nov 16, 2023 | Nov 20, 2023 | A · derivative | 450,000 | $1.87 | $841,500 | 450,000 | No | Form 4 |
| Hill Stephen J.Chief Technical Ops. Officer | Nov 16, 2023 | Nov 20, 2023 | D · derivative | 450,000 | $5.96 | $2,682,000 | not reported | No | Form 4 |
| Hill Stephen J.Chief Technical Ops. Officer | Nov 16, 2023 | Nov 20, 2023 | A · derivative | 100,000 | $1.87 | $187,000 | 100,000 | No | Form 4 |
| Hill Stephen J.Chief Technical Ops. Officer | Nov 16, 2023 | Nov 20, 2023 | D · derivative | 100,000 | $6.24 | $624,000 | not reported | No | Form 4 |
| Hill Stephen J.Chief Technical Ops. Officer | Nov 16, 2023 | Nov 20, 2023 | A · derivative | 85,000 | $1.87 | $158,950 | 85,000 | No | Form 4 |
| Hill Stephen J.Chief Technical Ops. Officer | Nov 16, 2023 | Nov 20, 2023 | D · derivative | 85,000 | $12.67 | $1,076,950 | not reported | No | Form 4 |
| Hill Stephen J.Chief Technical Ops. Officer | Nov 16, 2023 | Nov 20, 2023 | A · derivative | 700,000 | $1.87 | $1,309,000 | 700,000 | No | Form 4 |
| Hill Stephen J.Chief Technical Ops. Officer | Nov 16, 2023 | Nov 20, 2023 | D · derivative | 700,000 | $5.98 | $4,186,000 | not reported | No | Form 4 |
| Seely LynnPresident and CEO | Nov 16, 2023 | Nov 20, 2023 | A · derivative | 7,500,000 | $1.87 | $14,025,000 | 7,500,000 | No | Form 4 |
| Seely LynnPresident and CEO | Nov 16, 2023 | Nov 20, 2023 | D · derivative | 7,500,000 | $3.28 | $24,600,000 | not reported | No | Form 4 |
| Lee Gary K.Chief Scientific Officer | Nov 16, 2023 | Nov 20, 2023 | A · derivative | 800,000 | $1.87 | $1,496,000 | 800,000 | No | Form 4 |
| Lee Gary K.Chief Scientific Officer | Nov 16, 2023 | Nov 20, 2023 | D · derivative | 800,000 | $6.04 | $4,832,000 | not reported | No | Form 4 |
| Newton Charles W.Chief Financial Officer | Nov 16, 2023 | Nov 20, 2023 | A · derivative | 3,612,000 | $1.87 | $6,754,440 | 3,612,000 | No | Form 4 |
| Newton Charles W.Chief Financial Officer | Nov 16, 2023 | Nov 20, 2023 | D · derivative | 3,612,000 | $6.24 | $22,538,880 | not reported | No | Form 4 |
| Newton Charles W.Chief Financial Officer | Nov 16, 2023 | Nov 20, 2023 | A · derivative | 190,000 | $1.87 | $355,300 | 190,000 | No | Form 4 |
| Newton Charles W.Chief Financial Officer | Nov 16, 2023 | Nov 20, 2023 | D · derivative | 190,000 | $6.24 | $1,185,600 | not reported | No | Form 4 |
| Newton Charles W.Chief Financial Officer | Nov 16, 2023 | Nov 20, 2023 | A · derivative | 516,000 | $1.87 | $964,920 | 516,000 | No | Form 4 |
| Newton Charles W.Chief Financial Officer | Nov 16, 2023 | Nov 20, 2023 | D · derivative | 516,000 | $6.24 | $3,219,840 | not reported | No | Form 4 |
| Newton Charles W.Chief Financial Officer | Nov 16, 2023 | Nov 20, 2023 | A · derivative | 500,000 | $1.87 | $935,000 | 500,000 | No | Form 4 |
| Newton Charles W.Chief Financial Officer | Nov 16, 2023 | Nov 20, 2023 | D · derivative | 500,000 | $5.98 | $2,990,000 | not reported | No | Form 4 |